Jacob Gottlieb is back in the healthcare investment sector with a new company known as Altium Capital Management, LP. Between 2016 and mid-2017, he was out of investment activity and was winding up the operations of the former firm he worked with known as Visium Asset Management.
Gottlieb is passionate about matters of the healthcare industry, especially on investment. He is even regarded as the titan of the healthcare investment industry because of the success he has recorded in his career. He has risen to top positions in the industry by heading various successful hedge funds as a fund manager and CEO. Altium Capital is aligned based on his expertise and knowledge in healthcare investments. It is most likely to be the next big thing in the healthcare investment sector and will mark his successful comeback after the end of Visium Asset Management. With investors in the financial and healthcare industries expecting a good business environment in the future, Gottlieb is likely to be one of the best performers.
Gottlieb built Visium Asset Management and built it between 2005 and 2016. It became one of the key firms in the healthcare investment sector. It attracted high profile investors in the field of pension funds. With Visium, he brought together a team of professionals who assisted him to take the value of the asset of the company from $300 million to $8 billion. Gottlieb has previously worked with other companies such as Merlin Biomed Group, Sanford C. Bernstein, and Balyasny Asset Management. In these organizations, he created his reputation as a top portfolio manager.
The Rise of Altium Capital
After the end of Visium Asset Management, Jacob Gottlieb was ready to move on and establish a new firm. Altium Capital is the vehicle he is now using to run a successful healthcare investment business. The firm is benefiting from the good reputation of Jacob Gottlieb as a top investor in the healthcare industry. Altium is building a strong portfolio with investment in a few firms.
Altium has made a 5.61 percent investment at Oramed Pharmaceuticals Inc. Oramed Pharmaceuticals is developing alternative medical treatments. One of its main golas is to develop an oral drug as opposed to the injection drugs used for diabetes treatment. This method is going to reduce treatment costs, reduction of infections and improve patient comfort.
Other companies in Altium’s portfolio include Amarin, which develops cardiovascular drugs and Oragenics which develops antibiotics against infectious diseases.
The Lineup
Altium Capital under the leadership of Jacob Gottlieb is now a successful investment firm. He has added senior investment professionals in hedge funds and healthcare sector to assist him in running a successful business. The focus of the company is to generate from equity-focused products. Combined with fundamental analysis, Altium is ready to make investments that guarantee a high risk-reward ratio.
Growth Report
Altium Capital recently released its growth report, and the numbers are impressive. In five months of operation since opening doors in June 2018, it had made 7.37 percent returns. The results show that the company is most likely to perform very well in the long-term. Gottlieb is taking every possible measure to ensure that the ghost of Visium Management does not crawl into the new firm. He is observing due diligence, and that’s why the results have started coming out true. By seeking out firms that offer important health and medical treatment methods, the firm will boost the healthcare sector while at the same time befitting from the proceeds of growth in top companies. Gottlieb is a big name in the industry, and his prowess will come out clearly as Altium Capital does more business.
